The Esr Tubes Market, estimated at USD 137.2 Mn in 2025, is expected to exhibit a CAGR of 5.6% and reach USD 200.9 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
The key market players are focusing on adoption of growth strategies such as product launches, acquisition, and increasing technological advancements activities by the market players, and this is expected to drive the global ESR tubes market growth during the forecast period. For instance, in August 2025, Beckman Coulter, Inc., a company that engages in developing, manufacturing, and marketing of products that simplifies, automates, and innovates complex biomedical testing, and Iris Diagnostics Inc., a global consultancy and training firm that focuses on in vitro and medical device, announced the launch of the Alifax automated Erythrocyte Sedimentation Rate (ESR) analysis system through a distribution agreement with Alifax.
Global ESR Tubes Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spread quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of drugs from one place to another.
COVID-19 had negative impact on the global ESR tubes market owing to decrease and delay in diagnostics screening. For instance, on May 02, 2025, according to an article published by Journal of Diagnostics Journal, the diagnosis rate of blood infections decreased by 4.3% in 2025 as compared to 2025 due to COVID-19 outbreak. Despite the decreased diagnosis in 2025, an increase by 6.3% in 2025 compared to 2025 is seen in blood infections.
Global ESR Tubes Market: Key Developments
In December 2025, NIHON KOHDEN CORPORATION, a Japan-based manufacturer, developer, and distributor of medical electronic equipment, launched MEK-1305 Celltac α+, an Automated Hematology and ESR Analyzer. MEK-1305 is the world’s first hematology analyzer that can measure complete blood count (CBC) including white blood cell 3-part differential and erythrocyte sedimentation rate (ESR) simultaneously. The company developed MEK-1305 based on the concept of providing rapid and accurate test results, which are important for understanding the clinical condition of patients.
In July 2025, CellaVision, a U.S.-based provider of digital hematology microscopy solutions, announced the launch of DIFF-Line, a new workflow solution for low-volume hematology laboratories, at the (AACC) American Association for Clinical Chemistry convention in Chicago.
In November 2025, Sclavo Diagnostics International, an Italy-based research, development, production and marketing of in vitro clinical diagnostic company, announced the launch of new ESR analyzer. The instrument has 10 positions for delivering, with continuous loading capacity, and performs the test using the same blood count sample.
Browse 32 Market Data Tables and 36 Figures spread through 176 Pages and in-depth TOC on “Global ESR Tubes Market”- Forecast to 2032, Global ESR Tubes Market, By Material Type (Plastic and Glass), By End User (Hospitals, Specialty Centers, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/esr-tubes-market-4230
Key Takeaways of the Global ESR Tubes Market:
- Global ESR tubes market is expected to exhibit a CAGR of 5.6% during the forecast period due to increasing prevalence of blood infections. For instance, in May 2025, according to an article published by Journal of Tropical Medicine, globally, bloodstream infection affects about 30 million people causing up to 6 million deaths, with 3 million newborns, and 1.2 million children suffering from sepsis annually.
- Among end user, the hospitals segment is expected to dominate the global ESR tubes market over the forecast period due toincreasing hospitalization rates due to increasing arthritis prevalence. For instance, in December 2025, according to an article published by Journal of Cureus, hospitalization rates of Rheumatoid arthritis (RA) is more as compared to the cardiovascular diseases and other chronic disease. Rheumatologic disorders were the second most common ICD (International Classification of Diseases) category for hospitalization, however, RA was the 25th most common principal diagnosis for hospitalization.
- Major players operating in the global ESR tubes market include Greiner Bio-One International GmbH, DWK LIFE SCIENCES LLC, OCULUS, ELITech Group, Thomas Scientific, STRECK, Geisinger Health, SOL-Millennium, Henso Medical (Hangzhou) Co.,Ltd., BD (Becton, Dickinson and Company), Zhejiang Gongdong Medical Technology Co., Ltd., ESBE Scientific Industries Inc., Medline Industries, Inc., KARTELL SPA VIA DELLE INDUSTRIE, SANLI Medical & Health Service, DD Biolab S.L., VACUTEST KIMA S.r.l, and Laboratory Corporation of America Holdings.
Contact Us